Author: Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hochwald S, Hofstetter WL, Ilson DH, Johung KL, Keswani RN, Kim S, Kleinberg LR, Klempner S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Park H, Perry KA, Pimiento J, Poultsides GA, Roses RE, Strong VE, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA
Year: 2020
AGREE II score: Available
Developer organization: National Comprehensive Cancer Network
Type of cancer: Gastrointestinal
Patient population: Adult, Pediatric
Location: International
This is a clinical practice guideline for patients with gastric cancer. The guideline examines the pathology, initial workup, staging, treatment, follow-up, and supportive care of these patients. Treatment options discussed include lymph node dissection, laparoscopic resection, endoscopy, radiation therapy, combined modality therapy, chemotherapy (preoperative, perioperative, and postoperative), and targeted therapies.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 47.2%
Applicability: 25%
Stakeholder involvement: 44.4%
Editorial independence: 66.7%
Rigour: 70.8%
Clarity presentation: 61.1%
